@xconomy.com 4 years ago
With $45M, Mammoth Bio Expects Big Things From Tiny CRISPR Cas14
@xconomy.com 4 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further
@xconomy.com 5 years ago
After Scoring New Capital, Fifth Eye Prepares to Seek FDA Approval
@xconomy.com 5 years ago
AgileCraft’s Exit, $45M for Ojo Labs, Intel Grants & More TX Tech
@xconomy.com 5 years ago
GrainChain, Chargify, Q2, Hypergiant, NASA Tech & More TX Tech
@xconomy.com 5 years ago
Shine Raises $30M, Could Add $150M More After Inking Deerfield Deal
@xconomy.com 5 years ago
Delivery Robots in Big D, Rodriguez Leaves the Station, & More TX Tech
@xconomy.com 5 years ago
The Biggest Wisconsin Venture Round of the Decade… Didn’t Happen
@xconomy.com 5 years ago
Strangeworks, TMCx, SeriesX, Unchained Capital, ALTR, & More TX Tech
@xconomy.com 5 years ago
Pfizer, Merck Lead Strata Oncology’s $26M Series B Round